Technetium-99m tetrofosmin uptake in lung cancer: comparison with thallium-201. 1996

I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
Department of Radiology, Fukui Prefectual Hospital.

Technetium-99m tetrofosmin and thallium-201 lung SPECT imaging were performed in a patient with adenocarcinoma of the lung. Significant activities in the lung lesion were clearly depicted on both technetium-99m tetrofosmin and thallium-201 SPECT imaging. The early uptake, delayed uptake ratios and retention indices of the tumor were 2.75, 2.39 and -1.31 for thallium-201 imaging and 3.09, 2.27 and -26.5 for technetium-99m tetrofosmin imaging, respectively. This preliminary report suggests that technetium-99m tetrofosmin may have potential as a tumor imaging agent.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013794 Thallium Radioisotopes Unstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes. Radioisotopes, Thallium
D014057 Tomography, X-Ray Computed Tomography using x-ray transmission and a computer algorithm to reconstruct the image. CAT Scan, X-Ray,CT Scan, X-Ray,Cine-CT,Computerized Tomography, X-Ray,Electron Beam Computed Tomography,Tomodensitometry,Tomography, Transmission Computed,X-Ray Tomography, Computed,CAT Scan, X Ray,CT X Ray,Computed Tomography, X-Ray,Computed X Ray Tomography,Computerized Tomography, X Ray,Electron Beam Tomography,Tomography, X Ray Computed,Tomography, X-Ray Computer Assisted,Tomography, X-Ray Computerized,Tomography, X-Ray Computerized Axial,Tomography, Xray Computed,X Ray Computerized Tomography,X Ray Tomography, Computed,X-Ray Computer Assisted Tomography,X-Ray Computerized Axial Tomography,Beam Tomography, Electron,CAT Scans, X-Ray,CT Scan, X Ray,CT Scans, X-Ray,CT X Rays,Cine CT,Computed Tomography, Transmission,Computed Tomography, X Ray,Computed Tomography, Xray,Computed X-Ray Tomography,Scan, X-Ray CAT,Scan, X-Ray CT,Scans, X-Ray CAT,Scans, X-Ray CT,Tomographies, Computed X-Ray,Tomography, Computed X-Ray,Tomography, Electron Beam,Tomography, X Ray Computer Assisted,Tomography, X Ray Computerized,Tomography, X Ray Computerized Axial,Transmission Computed Tomography,X Ray Computer Assisted Tomography,X Ray Computerized Axial Tomography,X Ray, CT,X Rays, CT,X-Ray CAT Scan,X-Ray CAT Scans,X-Ray CT Scan,X-Ray CT Scans,X-Ray Computed Tomography,X-Ray Computerized Tomography,Xray Computed Tomography
D015609 Organotechnetium Compounds Organic compounds that contain technetium as an integral part of the molecule. These compounds are often used as radionuclide imaging agents. Compounds, Organotechnetium

Related Publications

I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
February 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
May 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
September 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
April 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
August 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
December 1996, European journal of nuclear medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
February 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
November 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
November 1993, The American journal of cardiology,
I Matsunari, and S Kinuya, and T Nishikawa, and M Matoba, and K Murakita, and M Ohguchi, and K Ichiyanagi, and J Taki, and N Tonami, and K Hisada
August 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!